Immunoregulatory pathways following strong inflammatory processes markedly impair CD4+ T cell responses

Human Vaccines and Immunotherapeutics

Volumn 12, Issue 9, 2016, Pages 2249-2252

  Minnar, Christine M ^a   Murphy, William J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

memory T cell expansion; primary antigen specific response; T cell activation

Indexed keywords

CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL EXPANSION; CELL FUNCTION; CYTOKINE RESPONSE; CYTOKINE RESPONSIVE ELEMENT; HUMAN; IMMUNE RESPONSE; IMMUNOTHERAPY; INFLAMMATION; NONHUMAN; NOTE; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; ANIMAL; IMMUNOLOGY; PROCEDURES;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; HUMANS; IMMUNOTHERAPY; INFLAMMATION;

EID: 84978536205     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.1080/21645515.2016.1174357     Document Type: Note

References (15)

1. J.M.Curtsinger, C.S.Schmidt, A.Mondino, D.C.Lins, R.M.Kedl, M.K.Jenkins and M.F.Mescher. Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells. JI 1999; 162:3256-62
2. T.Yamamoto, M.Hattori, and T.Yoshida. Induction of T-cell activation or anergy determined by the combination of intensity and duration of T-cell receptor stimulation, and sequential induction in an individual cell. Immunology 2007; 121:383-91; PMID:17376194; http://dx.doi.org/10.1111/j.1365-2567.2007.02586.x
3. R.H.Schwartz. T cell anergy:is there a common molecular mechanism? JEM 1996; 184(1):1-8; http://dx.doi.org/10.1084/jem.184.1.1
4. C.Bitegye, S.Hannier, S.Guérif, S.Valitutti, S.Demotz. Tuning of T Cell clone size and activation threshold by control of CD25 expression through mitogen-activated protein kinase pathways. Int Arch Allergy and Immunol 2002; 127:322-32; http://dx.doi.org/10.1159/000057750
5. O.Acuto and M.Frederique. CD28-mediated co-stimulation:a quantitative support for TCR signalling. Nat Rev Immunol 2003; 3:939-51; PMID:14647476; http://dx.doi.org/10.1038/nri1248
6. G.D.Sckisel, M.N.Bouchlaka, A.M.Monjazeb, M.Crittenden, B.D.Curti, D.E.C.Wilkins, K.A.Alderson, C.M.Sungur, E.Ames, A.Mirsoian, et al. Out-of-Sequence signal 3 paralyzes primary CD4+T-cell-dependent immunity. Immunity 2015; 43:240-50; PMID:26231116; http://dx.doi.org/10.1016/j.immuni.2015.06.023
7. S.L.Urban, R.M.Welsh. Out-of-Sequence signal 3 as a mechanism for virus-induced immune suppression of CD8 T cell responses. PLoS Pathogens 2014; 10:e1004357; PMID:25255454; http://dx.doi.org/10.1371/journal.ppat.1004357
8. R.H.Schwartz. T cell anergy. Annu Rev Immunol 2003; 21:305-34; PMID:12471050; http://dx.doi.org/10.1146/annurev.immunol.21.120601.141110
9. J.Geginat, F.Sallusto, A.Lanzavecchia. Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4(+) T cells. JEM 2001; 194:1711-9; http://dx.doi.org/10.1084/jem.194.12.1711
10. M.Berard and D.F.Tough. Qualitative differences between naïve and memory T cells. Immunology 2002; 106:127-38; PMID:12047742; http://dx.doi.org/10.1046/j.1365-2567.2002.01447.x
11. J.K.Tietze, D.E.C.Wilkins, G.D.Sckisel, M.N.Bouchlaka, K.L.Alderson, J.M.Weiss, E.Ames, K.W.Bruhn, N.Craft, R.H.Wiltrout, et al. Delineation of antigen-specific and antigen-nonspecific CD8+ memory T-cell responses after cytokine-based cancer immunotherapy. Blood 2012; 119:3073-83; PMID:22251483; http://dx.doi.org/10.1182/blood-2011-07-369736
12. S.Ehl, J.Hombach, P.Aichele, H.Hengartner and R.M.Zinkernagel. Bystander activation of cytotoxic T cells:Studies on the mechanism and evaluation of in vivo significance in a transgenic mouse model. JEM 1997; 185:1241-51; http://dx.doi.org/10.1084/jem.185.7.1241
13. A.M.Monjazeb, J.K.Tietze, S.K.Grossenbacher, H.H.Hsiao, A.E.Zamora, A.Mirsoian, B.Koehn, B.R.Blazar, J.M.Weiss, R.H.Wiltrout, et al. Bystander activation and anti-tumor effects of CD8+ T cells following interleukin-2 based immunotherapy is independent of CD4+ T cell help. PLoS ONE 2014; 9:e102709; PMID:25119341; http://dx.doi.org/10.1371/journal.pone.0102709
14. V.Berner, H.Liu, Q.Zhou, K.L.Alderson, K.Sun, J.M.Weiss, T.C.Back, D.L.Longo, B.R.Blazar, R.H.Wiltrout, et al. IFN-gamma mediates CD4+ T-cell loss and impairs secondary antitumor responses after successful initial immunotherapy. Nat Med 2007; 13:354-60; PMID:17334371; http://dx.doi.org/10.1038/nm1554
15. D.C.Palmer and N.P.Restifo. Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function. Trends Immunol 2009; 30:592-602; PMID:19879803; http://dx.doi.org/10.1016/j.it.2009.09.009